Article by Selcia Scientist on Fragment-based Drug Discovery Published

An article by Bob Carling at Selcia Ltd. on Screening Techniques for Fragment-Based Drug Discovery has been published in Innovations in Pharmaceutical Technology (IPT) magazine.

Bob advocates a combination of technologies for the identification of effective compounds in fragment-based drug discovery.

Keywords: High-throughput screening (HTS) Fragment-based drug discovery (FBDD) Surface plasmon resonance (SPR) Biolayer interferometry (BLI) Capillary electrophoresis (CE)

To read the full article please follow this link.

You can access the e-magazine via the following link (our article on p 10)